Austin American-Statesman March 12, 2023
Nicole Villalpando

Health care will be more personalized because that’s what consumers want, said Anne Wojcicki, the co-founder and CEO of 23andMe genomics profile company, in a conversation with Bloomberg’s Emily Chang on Friday afternoon at South by Southwest.

Here are five takeaways from that conversation:

AI is here to stay

“I remember in ’99 and 2000 when people were hypothesizing about the internet,” Wojcicki said. … “This is a moment where things are shifting.”

It’s not a question of whether to use artificial intelligence, but how to use it, she said.

“The...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Conferences / Podcast, Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider, Technology, Trends
Boehringer signs $1.3B deal with RNA biotech Ochre Bio to team up against MASH
Bristol Myers taps startup to boost cell therapy production
With $380M deal, Bristol Myers Squibb ups the ante with cell therapy manufacturer Cellares
Boehringer Ingelheim Strikes Regenerative Med R&D Deal Spanning MASH & More Liver Diseases
Metsera Launches with $290M to Develop Next Generation Weight Loss Products

Share This Article